Hospira (nyse: HSP - news - people ), a 2004 spinoff of a specialty pharmaceuticals operation of Abbott Laboratories (nyse: ABT - news - people ), benefited from pleasantly surprising Wall Street. In early May, its share price jumped 9% after the company beat quarterly earnings expectations by 14 cents.
Bargain hunters take note: At 20 times projected earnings for the coming 12 months, Hospira is cheaper than the average estimated earnings multiple of 26 for its industry peers.
<Taxes on the fruits of one's labors at death are, of course, wrong. Plute naturally believes more taxes will perserve or even increase his ridiculous dole from the poor over-taxed citizenry as he merrily triple dips.
I'm concerned about Plute's politics. As with most closet liberals, they can be identified by their sly criticisms, second guessing and elitist views (often elite because of someone else's doings).>
The heiress had a terrible impact. The domestic squabble would end with Turtle on the floor.
Right now I have a good bit of ECA. I have owned it for 4 yrs and sold some then added back recently. It has been strong lately. Oil, gas and oil sands. Also it has gotten rid of much overseas holdings.
I did own SJT which is a US NG trust. It is getting cheap IMO and pays 8+%